Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. ( fly 12.5 μl of binding buffer wit...)

Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.

fly, 12.5 μl of binding buffer without (total binding determination) or with motilin at 1 μM final concentration (non-specific binding determination) were first added to membrane-coated FlashPlate microplates, followed by the addition of 12.5 μl [¹²⁵I]-motilin. Incubation was performed at room temperature for 1 to 5 hours before counting on a PerkinElmer TopCount instrument (30 seconds/well).

K_d and K_i values were calculated using GraphPad Prism Software. Signal to background ratio (S/B) (total values/ nonspecific values) was calculated using a concentration of radioligand close to the K_d value.

Results and Discussion

Saturation Binding Assays
Membranes from CHO cells expressing the human motilin MTL-R1A receptor were immobilized into 96-well FlashPlate microplates and the affinity of [¹²⁵I]-motilin for the receptor was determined. Saturation experiments using motilin ScreenReady Targets were performed on the day of membrane immobilization (Figure 2, A) or upon storage at 4C for three months (Figure 2, B). A similar single class of high affinity binding sites was detected from the saturation experiment performed on the day of membrane immobilization or after three months upon storage at 4C (K_d = 1.0 nM and 0.75 nM, respectively). Calculated K_d values were comparable to those previously reported (Feighner et al ., 1999; Thielemans et al ., 2001). B_max values were also very similar in both assays (4.3 pmol/mg at t= 0 and 3.6 pmol/mg at t= 3 months). S/B values calculated at a concentration of radioligand close to the K_d value were comparable in both assays (5.1 vs. 4.6), showing that the immobilized motilin receptor maintained its pharmacological binding properties for at least three months at 4C.

<

Source:

Page: All 1 2 3 4 5
Related biology technology :

1. The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis
2. Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins
3. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
4. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
5. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
6. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
7. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
8. Development of an adrenergic α2a receptor binding assay using the LEADseeker Multimodality Imaging System
9. Development of a CRF1 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
10. Purification of the Components of Human Macular Carotenoid-Binding Complex, Rev A
11. Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor

Post Your Comments:

( fly 12.5 μl of binding buffer wit...)Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.